210240-20-3 Usage
General Description
4-Aminotetrahydro-2H-thiopyran 1,1-dioxide is a chemical compound with the molecular formula C5H11NOS. It is an organic compound consisting of a five-membered heterocyclic ring with a nitrogen and sulfur atom. 4-Aminotetrahydro-2H-thiopyran 1,1-dioxide is often used as a building block in organic synthesis for the production of pharmaceuticals and agrochemicals. It has also been studied for its potential pharmacological properties, particularly in anti-inflammatory and anti-cancer research. Additionally, its unique structure and reactivity make it a valuable tool in the field of organic chemistry for creating new chemical compounds and materials.
Check Digit Verification of cas no
The CAS Registry Mumber 210240-20-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,0,2,4 and 0 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 210240-20:
(8*2)+(7*1)+(6*0)+(5*2)+(4*4)+(3*0)+(2*2)+(1*0)=53
53 % 10 = 3
So 210240-20-3 is a valid CAS Registry Number.
InChI:InChI=1/C5H11NO2S/c6-5-1-3-9(7,8)4-2-5/h5H,1-4,6H2
210240-20-3Relevant articles and documents
-
Barkenbus,Wuellner
, p. 3866,3867 (1955)
-
1-(DIHYDRONAPHTHALENYL)PYRIDONES AS MELANIN-CONCENTRATING HORMONE RECEPTOR 1 ANTAGONISTS
-
, (2013/10/22)
Provided are 1-(dihydronaphthalenyl)pyridones which are antagonists at the melanin-concentrating hormone receptor 1 (MCHR1), pharmaceutical compositions containing them, processes for their preparation, and their use in therapy for the treatment of obesity and diabetes.
SOLUBLE EPOXIDE HYDROLASE INHIBITORS
-
Page/Page column 24, (2009/04/24)
Disclosed are amide, thioamide, urea and thiourea compounds and compositions that inhibit soluble epoxide hydrolase (sEH), methods for preparing the compounds and compositions, and methods for treating patients with such compounds and compositions. The compounds, compositions, and methods are useful for treating a variety of sEH mediated diseases, including hypertensive, cardiovascular, inflammatory, and diabetic-related diseases.